Currently, parties to the Convention on Biological Diversity (CBD) are negotiating a strategic plan to save biodiversity. One crucial element of an agreement is the question of whether and how digital sequence information (DSI) is subject to access and benefit-sharing from the utilization of genetic resources, one main instrument of the CBD. In the EU, the Open Data Directive (ODD) of 2019 and the recently adopted Data Governance Act (DGA) already cover research data and to some extent DSI. An analysis of the ODD and the DGA throws a spotlight on the legal uncertainty of utilizing DSI and reveals systemic tensions between open data principles and benefit-sharing restrictions on non-commercial use. It also suggests that a future benefit-sharing mechanism for DSI should avoid distinguishing between commercial and non-commercial use upstream, but should instead favor a solution, which imposes benefit-sharing obligations further downstream or outside of the DSI life cycle.

中文翻译：

---

利益共享与开放数据之间的数字序列信息

目前，《生物多样性公约》（CBD）的缔约方正在就一项拯救生物多样性的战略计划进行谈判。一项协议的一个关键要素是数字序列信息 (DSI) 是否以及如何受遗传资源利用的获取和惠益分享的问题，这是 CBD 的一项主要文书。在欧盟，2019 年的开放数据指令 (ODD) 和最近通过的数据治理法案 (DGA) 已经涵盖了研究数据，并在一定程度上涵盖了 DSI。对 ODD 和 DGA 的分析突出了使用 DSI 的法律不确定性，并揭示了开放数据原则与非商业用途的利益分享限制之间的系统性紧张关系。它还建议 DSI 未来的利益分享机制应避免区分上游的商业和非商业用途，